BIOMAT Database Logo BIOMAT Database Logo

High-dose dietary myo-inositol supplementation does not alter the ischaemia phenomenon in human diabetics. 1989

K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
Department of Endocrinology, Ribe County Hospital, Esbjerg, Denmark.

Five diabetic patients and 3 non-diabetics were subjected to a dietary supplement of 20 g per day of myo-inositol (40 X the normal ingestion) for 14 days. This amount neither produced toxic side-effects nor changed the peripheral nervefunction expressed by motor conduction velocity or resistance to ischaemia.

UI MeSH Term Description Entries
D007294 Inositol An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction. Myoinositol,Chiro-Inositol,Mesoinositol,Chiro Inositol
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003929 Diabetic Neuropathies Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325) Diabetic Amyotrophy,Diabetic Autonomic Neuropathy,Diabetic Neuralgia,Diabetic Polyneuropathy,Neuralgia, Diabetic,Asymmetric Diabetic Proximal Motor Neuropathy,Diabetic Asymmetric Polyneuropathy,Diabetic Mononeuropathy,Diabetic Mononeuropathy Simplex,Diabetic Neuropathy, Painful,Mononeuropathy, Diabetic,Symmetric Diabetic Proximal Motor Neuropathy,Amyotrophies, Diabetic,Amyotrophy, Diabetic,Asymmetric Polyneuropathies, Diabetic,Asymmetric Polyneuropathy, Diabetic,Autonomic Neuropathies, Diabetic,Autonomic Neuropathy, Diabetic,Diabetic Amyotrophies,Diabetic Asymmetric Polyneuropathies,Diabetic Autonomic Neuropathies,Diabetic Mononeuropathies,Diabetic Mononeuropathy Simplices,Diabetic Neuralgias,Diabetic Neuropathies, Painful,Diabetic Neuropathy,Diabetic Polyneuropathies,Mononeuropathies, Diabetic,Mononeuropathy Simplex, Diabetic,Mononeuropathy Simplices, Diabetic,Neuralgias, Diabetic,Neuropathies, Diabetic,Neuropathies, Diabetic Autonomic,Neuropathies, Painful Diabetic,Neuropathy, Diabetic,Neuropathy, Diabetic Autonomic,Neuropathy, Painful Diabetic,Painful Diabetic Neuropathies,Painful Diabetic Neuropathy,Polyneuropathies, Diabetic,Polyneuropathies, Diabetic Asymmetric,Polyneuropathy, Diabetic,Polyneuropathy, Diabetic Asymmetric,Simplex, Diabetic Mononeuropathy,Simplices, Diabetic Mononeuropathy
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D048909 Diabetes Complications Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE. Complications of Diabetes Mellitus,Diabetes-Related Complications,Diabetic Complications,Diabetes Complication,Diabetes Mellitus Complication,Diabetes Mellitus Complications,Diabetes Related Complications,Diabetes-Related Complication,Diabetic Complication

Related Publications

K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
Dietary myo-inositol supplementation does not prevent retinal and glomerular vascular structural changes in chronically diabetic rats.
January 1993, Journal of diabetes and its complications,
K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS.
August 1996, Biological psychiatry,
K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes.
February 2023, The Cochrane database of systematic reviews,
K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: benefits of a dietary myo-inositol supplementation.
June 2015, The British journal of nutrition,
K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol.
October 2007, Neuroreport,
K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes.
December 2018, International journal of nursing practice,
K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes.
September 2016, The Cochrane database of systematic reviews,
K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
Dietary Nitrate Supplementation Does Not Alter Exercise Efficiency at High Altitude - Further Results From the Xtreme Alps Study.
January 2022, Frontiers in physiology,
K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
The Myo-inositol pathway does not contribute to ascorbic acid synthesis.
January 2019, Plant biology (Stuttgart, Germany),
K Arendrup, and G Gregersen, and J Hawley, and J N Hawthorne
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
January 2007, Asia Pacific journal of clinical nutrition,
Copied contents to your clipboard!